State of California Report issue

Government Phase 1 Phase 2

Organization Overview

First Clinical Trial
1995
NCT00277225
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

California Department of Health Services | California Department of Motor Vehicles | California Institutional Review Board | Imperial Valley Regional Occupational Program (IVROP) | Public Health Behavior Solutions/State of California

Active Ingredients

Drugs in Phase 2 Trials (1)

cannabis (1 trial)

Drugs in Phase 1 Trials (1)

abatacept (orencia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Psoriasis (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2